Start for free
Start for free
WF

Watson Fund

North America, Washington, United States, Seattle

Description

Healthcare venture capital fund that specializes in early-stage investments in a broad range of life science opportunities.

Investor Profile

Watson Fund has made 6 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (83%)
  • Series B (17%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Life Science
  • Neuroscience
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Watson Fund frequently co-invest with?

Alexandria
Alexandria
North America, California, United States, San Francisco
Co-Investments: 3
Accelerator Life Science Partners
Accelerator Life Science Partners
North America, New York, United States, New York
Co-Investments: 4
Partnership Fund for New York City
Partnership Fund for New York City
North America, New York, United States, New York
Co-Investments: 3
Johnson & Johnson Robotics and Digital Solutions
Johnson & Johnson Robotics and Digital Solutions
North America, New Jersey, United States, New Brunswick
Co-Investments: 5
180 Degree Capital
180 Degree Capital
North America, New Jersey, United States, Montclair
Co-Investments: 3
WuXi AppTec
WuXi AppTec
Asia, Shanghai, China, Shanghai
Co-Investments: 5
Empire State Development
Empire State Development
North America, New York, United States, New York
Co-Investments: 3
AbbVie Biotech Ventures
AbbVie Biotech Ventures
North America, Illinois, United States, North Chicago
Co-Investments: 3
Eli Lilly
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 4
ARCH Venture Partners
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 6

What are some of recent deals done by Watson Fund?

Proniras

Seattle, Washington, United States

Proniras focuses on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury.

BiotechnologyHealth CareLife SciencePharmaceutical
Series BFeb 1, 2024
Amount Raised: $4,650,000
Magnolia NeuroSciences

New York, New York, United States

Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.

BiotechnologyHealth CareNeuroscienceWellness
Series AAug 13, 2018
Amount Raised: $31,000,000
Rodeo Therapeutics

Seattle, Washington, United States

Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.

BiotechnologyPharmaceuticalTherapeutics
Series AJul 25, 2017
Amount Raised: $5,900,000
ApoGen Biotechnologies

Seattle, Washington, United States

ApoGen Biotechnologies, Inc. is a biotechnology company focused on the development of a new class of therapeutics.

BiotechnologyHealth CarePharmaceutical
Series ADec 12, 2016
Amount Raised: $7,000,000
Lodo Therapeutics

New York, New York, United States

Lodo Therapeutics is a drug discovery and development company.

BiotechnologyHealth CarePharmaceutical
Series AJan 11, 2016
Amount Raised: $17,000,000
Petra Pharma

New York, New York, United States

Petra Pharma is a clinical-stage pharmaceutical company developing a diverse portfolio of novel therapies.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series AJan 6, 2016
Amount Raised: $48,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator